Organization
Taofeek Owonikoko
2 clinical trials
Clinical trial
A Phase 2 Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2027-08-01
Clinical trial
A Phase 1b Trial of Adaptive Stereotactic Body Radiotherapy in Combination With Durvalumab (MEDI4736), Platinum, and Etoposide in Extensive Stage Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-02-01